The Hypo-RESOVLE consortium is very pleased to announce that the IMI approved an 18 months’ no-cost extension of the Hypo-RESOLVE action end of April 2022. The project will now terminate in October 20...
On 15th March 2022, the Hypo-RESOLVE Managing Board gathered online to discuss the action’s progress and plan work for the no-cost project extension, which has been requested with the IMI2 JU to allow...
Making sure that the Hypo-RESOLVE results change the diabetes (research) landscape for the better, is one of our most important goals. For our last episode, we have invited Jens Heisterberg from Novo...
Patient-Reported Outcome (PRO) Measures reliably assess the psychological impact of hypoglycaemia. Our seventh episode features researchers Dr Jill Carlton and Dr Philip Powell from the University of...
Diabetes and hypoglycaemia extend beyond physical effects and can become a psychological burden as well. Today’s episode features Melanie Broadley from the University of Southern Denmark and Renza Sci...
What are the implications of hypoglycaemic episodes that are underneath the detection threshold of current glucose measuring devices? This is what the Hypo-METRICS study set out to determine. Our podc...